Biosimilars: Interchangeable Products May Increase Patient Access

Depending on state pharmacy laws, pharmacies might be able to substitute an interchangeable biosimilar product for the original product prescribed — just as they might substitute a generic drug for a brand-name one. This helps increase patient access to biologics and may reduce patient costs.

Learn more about Interchangeable Biological Products from the FDA, and be sure to bookmark the FDA’s Biosimilars webpage and materials for health care providers and patients.

Additional FDA resources you may find helpful:

• Overview of Biosimilar Products
• Biosimilar Regulatory Review and Approval (PDF)